![]() Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. | ![]() NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies | ![]() Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. | ![]() Paion PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs. | ||
Founding Date | Founding Date 1948 | Founding Date 2006 | Founding Date 2006 | Founding Date N/A | Founding Date 2000 |
Type | Type Subsidiary | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Emeryville, US HQ Maidenhead, GB | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US | Locations Cupertino, US HQ | Locations Aachen, DE HQ Odense, DK Hoofddorp, NL Richmond, GB | |
Employees | Employees 619 | Employees 731% decrease | Employees 92 | Employees 902% increase | Employees 3218% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 340.9 m | Valuation ($) 45.3 m | Valuation ($) 49.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) £17k (FY, 2016) | Revenue (est.) $8.5m (FY, 2023) | Revenue (est.) €33.2m (FY, 2022) |
Cost of goods | Cost of goods £221m (FY, 2019) | Cost of goods $4.8m (FY, 2021) | Cost of goods N/A | Cost of goods $1.7m (FY, 2023) | Cost of goods €382k (FY, 2022) |
Gross profit | Gross profit £510.3m (FY, 2019) | Gross profit N/A | Gross profit N/A | Gross profit $6.8m (FY, 2023) | Gross profit €33.4m (FY, 2022) |
Net income | Net income £88.3m (FY, 2019) | Net income ($227.4m) (FY, 2021) | Net income £17k (FY, 2016) | Net income ($27.6m) (FY, 2023) | Net income (€579k) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 122.8m | Total funding raised $ 20m | Total funding raised $ 15.2m |
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View companyNIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies
View companyDURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View companyPAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
View company